Blog

ARMO BioSciences Announces Clinical Data Presentation for Immunotherapy AM0010 at the 12th European … – Yahoo Finance

ARMO BioSciences Announces Clinical Data Presentation for Immunotherapy AM0010 at the 12th European …
Yahoo Finance
REDWOOD CITY, Calif., April 21, 2017 /PRNewswire/ — ARMO BioSciences, Inc., a late-stage immuno-oncology company, today announced that clinical data on the Company's lead investigational immuno-oncology drug AM0010 (PEGylated Interleukin-10) …

and more »

2017-04-21 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.